Logo
Vector Smart Object-ai Get A Quote

Customers

See how our customers win with us.
Check Out Our Products
See Applications

  • Industry: CDMO
  • CYTENA instruments in use: UP.SIGHT™
  • Cell type: iPSC

Cellistic is using the CYTENA UP.SIGHT to generate monoclonal gene-edited iPSCs

SEE CASE STUDY
 

  • Industry: Biopharma
  • CYTENA instruments in use: Single Cell Printer™
  • Cell type: CHO

Coupling CRISPR interference with FACS enrichment: New approach in glycoengineering of CHO cell lines for therapeutic glycoprotein production

ACCESS NOW
  • Industry: Biopharma
  • CYTENA instruments in use: F.SIGHT™
  • Cell type: HEK293

Rapid lentiviral vector producer cell line generation using a single DNA construct

ACCESS NOW
  • Industry: CDMO/CRO
  • CYTENA instruments in use: F.SIGHT™
  • Cell type: HEK293

A new T-antigen negative HEK293 cell line with improved AAV productivity

ACCESS NOW
  • Industry: CDMO
  • CYTENA instruments in use: B.SIGHT™
  • Cell type: Pichia Pastoris

Lonza and CYTENA combine expertise to allow biotherapeutic manufacturers to benefit from the advantages of pichia pastoris as an expression system

ACCESS NOW
  • Industry: Biopharma
  • CYTENA instruments in use: Single Cell Printer™
  • Cell type: CHO

Targeted Locus Amplification and NGS combined with qPCR-based breakpoint analysis for the assurance of monoclonality in recombinant cell lines

ACCESS NOW
  • Industry: Biotech
  • CYTENA instruments in use: Single Cell Printer™
  • Cell type: CHO

Achieving greater efficiency and higher confidence in single-cell cloning by combining cell printing and plate imaging technologies

ACCESS NOW
  • Industry: Biopharma
  • CYTENA instruments in use: F.SIGHT™
  • Cell type: Human CD34+ Cells

Generation of stable suspension producer cell lines for serum-free lentivirus production

ACCESS NOW
  • Industry: Academic
  • CYTENA instruments in use: Single Cell Printer™
  • Cell type: iPSC

Longer metaphase and fewer chromosome segregation errors in modern human than Neanderthal brain development

ACCESS NOW
  • Industry: CDMO/CRO
  • CYTENA instruments in use: F.SIGHT™
  • Cell type: CHO

Establishment of a CLD platform for generation of high titer CHO cell lines

ACCESS NOW
  • Industry: CDMO/CRO
  • CYTENA instruments in use: UP.SIGHT™ & C.STATION™
  • Cell type: iPSCs

Using iPSC and gene editing technologies to generate immune-cloaked “off-the-shelf” allogeneic cell therapies

ACCESS NOW
  • Industry: Academic
  • CYTENA instruments in use: UP.SIGHT™
  • Cell type: iPSCs

Single-cell cloning of human induced pluripotent stem cells

ACCESS NOW
  • Industry: Biopharma
  • CYTENA instruments in use: C.SIGHT™ & C.SIGHT™ 2.0
  • Cell type: HEK

High-titer rAAV production in bioreactors using ELEVECTA™ stable producer cell lines

ACCESS NOW
  • Industry: Biopharma
  • CYTENA instruments in use: Single Cell Printer™
  • Cell type: CHO

Establishing a robust workflow to indentify high-performing clones

ACCESS NOW
  • Industry: CDMO/CRO
  • CYTENA instruments in use: UP.SIGHT™
  • Cell type: CHO

Automation for dual clonality assurance and reduced timelines in CHO Cell Line Development

ACCESS NOW
  • Industry: Biotech
  • CYTENA instruments in use: F.SIGHT™
  • Cell type: Histiocytic Lymphoma

scPICO: Achieving unprecedented single-cell sensitivity – a reference-free absolute quantitative assay of proteoforms

ACCESS NOW
  • Industry: Biopharma
  • CYTENA instruments in use: Single Cell Printer™
  • Cell type: CHO

A robust workflow to identify high performing-clones

ACCESS NOW
  • Industry: CDMO/CRO
  • CYTENA instruments in use: F.SIGHT™
  • Cell type: HEK293

Lentiviral vector packaging and producer 2 cell lines yield titres equivalent to the 3 industry-standard four-plasmid process

ACCESS NOW
  • Industry: Academic
  • CYTENA instruments in use: UP.SIGHT™
  • Cell type: hESC

Establishment of heterozygous and homozygous SHANK3 knockout clonal pluripotent stem cells from the parental hESC line SA001 using CRISPR/Cas9

ACCESS NOW

Keep up with the latest
lab automation news by signing up
for our emails
Subscribe
Contact us
Navigation
Policies
Supplier code of conduct
Internal code of conduct
Whistleblower/speak-up channel

CYTENA is a part of BICO. Our products aim to reduce the
organ shortage and speed up drug development by
providing accessible life science solutions that combine
biology and technology, fundamentally shifting the global healthcare industry.

Read more at BICO.com

Linkedin Facebook Twitter Youtube
  • COPYRIGHT © 2024 CYTENA GmbH - All rights reserved.
  • Sitemap